Essential Thrombocythemia

Clinical

• Complications of thromboembolism and secondary hemorrhage
• <5% transformation to AML/MDS
  • Probably secondary to cytotoxic therapy
• Median survival 10-15 years
• Post-ET fibrosis is rare

You are Here:

Stanford Medicine » School of Medicine » Departments » Surgical Pathology Criteria »Essential Thrombocythemia

Navigation for This Section: Surgical Pathology Criteria

• Diagnostic Criteria
• Supplemental Studies
• Differential Diagnosis
• Clinical
• Classification/Lists
• Bibliography
• Printable Version

Additional Links: General Links

• Surgical Pathology Criteria Home
• Diseases and Disorders By Section
• Keyword Search
• Abbreviations
• Stanford Pathology Department
• To Submit a Specimen for Review:
• For Physicians
• For Patients

Stanford Medicine Resources:

• Stanford Medicine
• Getting Care
  • Overview
  • Find a Physician
  • Find a Clinical Care Center
  • Stanford Hospital & Clinics
  • Lucile Packard Children's Hospital
  • Emergency
• Research
  • Overview
  • School of Medicine
  • News & Resources
  • Clinical Trials
  • Departments, Institutes & Centers
  • Faculty Profiles
• Education & Training
  • Overview
  • School of Medicine
  • Programs
  • Admissions
  • Continuing Medical Education
  • Alumni
  • Lane Medical Library
• Community
  • Overview
  • Stanford Health Library
  • Community Newsletter
  • Volunteering
  • Public Service & Community Partnerships
  • Renewal & New Building Projects
• About Us
  • Overview
  • News
  • Careers
  • Ways to Give
  • Find a Person
  • Contact Us
  • Maps & Directions
  • The Dean's Newsletter
• Stanford University

Footer Links:

• Home

• ©2009 Stanford School of Medicine
• Terms of Use
• Powered by IRT